|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/505 | |
| A61K 31/55 | |||
| A61K 38/17 |
| (11) | Number of the document | 3058941 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16156290.5 |
| Date of filing the European patent application | 2008-09-10 | |
| (97) | Date of publication of the European application | 2016-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 971144 P | 2007-09-10 | US | |
| 13372 | 2007-12-13 | US |
| (72) |
JIANG, Zhiwei, US
LI, Chiang, Jia, US
LI, Wei, US
LEGGETT, David, US
|
| (73) |
Boston Biomedical, Inc.,
640 Memorial Drive, Cambridge, MA 02139,
US
|
| (54) | NOVEL STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL INHIBITORS |
| NOVEL STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL INHIBITORS |